» RELATED: 6 incredibly rare diseases you’ve probably never heard of
"This has been the thrill of my life," Dr. Richard Silver, a hematologist and oncologist in New York who helped test the drug in patients, told NBC News.
According to Silver, Gleevec is the first targeted personalized medicine ever used—and the most successful.
One of the surviving patients is Bharat Shah of Atlanta, who told NBC News he had six months to three years to live upon his diagnosis in 2000.
After joining a clinical trial of Gleevec, Shah said he was back to normal within two months. After 17 years using the drug, the only side effect is that his eyes get a little puffy.
Gleevec also proved effective against other forms of cancer, including pediatric CML and gastrointestinal stromal tumor (GIST), the study found.
Common side effects, according to the study, included nausea, fatigue, itchy skin and muscle pain.
More about the New England Journal of Medicine study on Gleevec.
Man, despite the odds, is close to new cancer-treatment drug